COPD Trial, Recruiting NCT06756646 Sponsor: National Cheng Kung University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06756646
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with COPD that has been rated as a moderate to very severe level (levels 2–4)
  • Your COPD has been stable, with no significant worsening, for at least the past three months
  • You have not taken part in any rehabilitation program in the last six months
  • You are able to understand and follow spoken instructions and can take part in an exercise training program

Who may not be able to join:

  • You are unconscious or unable to communicate and work with the research team
  • You have been hospitalized due to a sudden illness in the past three months
  • You have serious joint problems or have had surgery on your legs or lower limbs
  • You have a serious heart condition, such as having a heart pacemaker fitted or having had a heart attack within the past six months
  • You rely on oxygen equipment to breathe on a daily basis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kun-Ling Tsai, Ph.D., Department of Physical Therapy, National Cheng Kung University

Phone: 886-6-2353535

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Cheng Kung University
Registry
ClinicalTrials.gov
Start date
20 November 2024
Est. completion
31 December 2028

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Oxygen consumption (VO2); Diaphragm capacity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov